• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 5. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids and derivatives Hydroxycinnamic acids

Chemical Profile of (2E)-3-(2,5-Dihydroxyphenyl)acrylic Acid (CAS No. 636-01-1)

(2E)-3-(2,5-Dihydroxyphenyl)acrylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 636-01-1, is a significant compound in the realm of organic chemistry and pharmaceutical research. This molecule, characterized by its acrylic acid backbone and substituted hydroxyphenyl group, has garnered attention due to its versatile applications and potential in drug development. The presence of two hydroxyl groups on the aromatic ring enhances its reactivity, making it a valuable intermediate in synthesizing various bioactive molecules.

The structure of (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid consists of a conjugated system comprising an acrylic double bond and a phenolic moiety. This configuration allows for multiple functionalization pathways, enabling chemists to tailor its properties for specific applications. The molecule's ability to participate in hydrogen bonding and π-π interactions further extends its utility in medicinal chemistry and material science.

In recent years, research has highlighted the pharmacological significance of (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid. Studies have demonstrated its potential role in modulating inflammatory pathways and antioxidant activities. The hydroxyl groups on the phenyl ring contribute to its ability to scavenge free radicals, which is crucial in preventing oxidative stress-related diseases. Furthermore, the acrylic acid moiety can be further functionalized to develop novel therapeutic agents targeting neurological disorders, cancer, and cardiovascular diseases.

One of the most compelling aspects of (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid is its role as a precursor in synthesizing complex pharmacophores. Researchers have leveraged this compound to develop inhibitors of enzymes such as lipoxygenase and cyclooxygenase, which are pivotal in inflammatory responses. The structural features of this molecule allow for selective binding to target proteins, minimizing side effects associated with non-specific interactions.

Advances in computational chemistry have also facilitated the design of derivatives of (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid with enhanced pharmacokinetic properties. Molecular modeling studies have predicted that modifications at the acrylic double bond or the phenolic hydroxyl groups can improve solubility and bioavailability. These insights are guiding experimental efforts to optimize drug candidates for clinical trials.

The synthesis of (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid typically involves phenol derivatives and acrylic acid through condensation reactions. Catalytic methods have been explored to improve yield and purity, ensuring that the final product meets pharmaceutical standards. Green chemistry approaches are also being adopted to minimize waste and energy consumption during production.

In conclusion, (2E)-3-(2,5-Dihydroxyphenyl)acrylic acid (CAS No. 636-01-1) represents a promising compound in pharmaceutical research. Its unique structural features and reactivity make it a valuable building block for developing novel therapeutics. As research continues to uncover new applications and synthetic methodologies, this molecule is poised to play a significant role in addressing global health challenges.

• 614-60-8(2-Hydroxycinnamic acid)
• 614-86-8((2E)-3-(2,4-Dihydroxyphenyl)acrylic Acid)
• 113170-66-4(2-Propenoic acid, 3-(2-hydroxyphenyl)-, copper(2+) salt (2:1))
• 31082-90-3(3-(2,3-dihydroxyphenyl)prop-2-enoic acid)
• 54951-70-1(2-Propenoic acid, 3-(hydroxyphenyl)-, (Z)-)
• 583-17-5(3-(2-Hydroxyphenyl)acrylic acid)
• 38094-41-6(2-Propenoic acid, 3-(hydroxyphenyl)-, (2E)-)
• 89311-95-5(2-Propenoic acid, 3-(2-hydroxyphenyl)-, monopotassium salt)
• 27323-69-9(2-Propenoic acid, 3-(dihydroxyphenyl)-)
• 38481-04-8(2-Propenoic acid, 3-(2,3-dihydroxyphenyl)-, (2E)-)